SERPINA1 and COVID-19: Regardless of clinical outcome, patients in our COVID-19 cohort showed limited differences in most serum inflammatory markers, although the mean or median values of several markers, such as TNFα, ICAM-1, CRP, AAT, and ferritin, were higher in more severe patients.